PAVmed Receives $6.3 Million in Gross Proceeds from Completion of November 2019 Financing
PAVmed Inc. (PAVM)
US:NASDAQ Investor Relations:
ir.pavm.com
Company Research
Source: GlobeNewswire
NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has received $6.3 million in new gross proceeds from the prepayment of promissory notes issued in conjunction with a previously disclosed November 2019 private placement (the “Financing”). Maxim Group LLC acted as financial advisor to PAVmed in this transaction. On November 4, 2019, the Company consummated a $14 million private placement of senior secured convertible notes to two institutional investors (the “Investors”). The Financing generated $6.3 million in gross cash proceeds in exchange for the issuance of Series A Senior Secured Convertible Notes (the “Series A Notes”) and the delivery of $7 million in secured promissory notes (the “Investor Notes”) in exchange for the issuance of Series B Senior Secured Convertible Notes (the “Series B Notes”). On March 30, 2020, the Investors pr
Show less
Read more
Impact Snapshot
Event Time:
PAVM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PAVM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PAVM alerts
High impacting PAVmed Inc. news events
Weekly update
A roundup of the hottest topics
PAVM
News
- Why PAVmed Inc. (PAVM) Dipped More Than Broader Market Today [Yahoo! Finance]Yahoo! Finance
- Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- PAVmed Full Year 2023 Earnings: EPS Beats Expectations [Yahoo! Finance]Yahoo! Finance
- PAVmed Non-GAAP EPS of -$1.33 beats by $0.47, revenue of $1.05M beats by $0.02M [Seeking Alpha]Seeking Alpha
PAVM
Sec Filings
- 4/26/24 - Form 8-K
- 3/25/24 - Form 10-K
- 3/14/24 - Form 8-K
- PAVM's page on the SEC website